183 results
Page 5 of 10
8-K
EX-99.1
hcv0u
29 Apr 20
Diffusion Pharmaceuticals Announces Pre-IND Submission to the FDA of Design for TSC Trials to Treat Acute Respiratory Distress Syndrome in COVID-19
8:44am
8-K
EX-99.1
0wir zjs1nm90c27vhz
1 Apr 20
Partnering with University of Virginia Health and iTHRIV
4:41pm
8-K
EX-99.1
3q4skiltz7m40ewi223c
24 Mar 20
Diffusion Pharmaceuticals Anticipates Enrollment in its Ambulance-based Stroke Trial Will be Slowed Due to the Impact of the Coronavirus
4:41pm
8-K
EX-99.1
0u5tcldxf 27m
18 Mar 20
Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer
5:22pm
8-K
EX-99.2
qod4o299oj148uv
18 Mar 20
Diffusion Pharmaceuticals Announces Retirement of Chief Science Officer John L. Gainer
5:22pm
8-K
EX-99.1
whsoa n2zpso
13 Jan 20
Diffusion Pharmaceuticals Appoints Life Sciences Veteran Dr. Robert Cobuzzi, Jr. to its Board of Directors
4:16pm
424B3
qol6 fjbn3am1n3c5
30 Dec 19
Prospectus supplement
10:07am
8-K
EX-10.1
rk6e4hbju7ork8 ih5x
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-99.1
znb34e2s6uqdt8xo 8c
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-99.2
kw7np11bq2 mabz
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
424B5
63m lov6p0fdr
13 Dec 19
Prospectus supplement for primary offering
7:59am
8-K
EX-99.1
zf7rdaruw 6qx3z7xu
10 Dec 19
Presentation Made by Chief Scientific Officer John Gainer at the Inaugural Glioblastoma Drug Development Summit
4:25pm
8-K
EX-99.1
9zdd2 9tg
19 Nov 19
Chief Scientific Officer Dr. John Gainer to Present at Inaugural Glioblastoma Drug Development Summit
4:49pm
8-K
EX-99.1
ehyqdznrv4u4209o 4v
15 Nov 19
Diffusion Pharmaceuticals Announces Closing of $4.0 Million Public Offering
4:06pm
424B4
0zc 0zm8nak
15 Nov 19
Prospectus supplement with pricing info
12:00am
8-K
EX-10.2
irknok
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm